Gianluca Spitaleri
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 75 publications
Radiogenomic approach combining CT-based radiomics and liquid biopsy improves prognostic stratification in patients with advanced NSCLC.
Journal: The journal of liquid biopsy
Published: February 21, 2026
Epidermal Growth Factor Receptor (EGFR) atypical mutations in Non-Small-Cell Lung Cancer (NSCLC): 'where the streets have no name'.
Journal: Critical reviews in oncology/hematology
Published: February 03, 2026
Epidermal growth factor receptor (EGFR) atypical mutations in non-small-cell lung cancer (NSCLC): 'Where the streets have no name'.
Journal: Critical reviews in oncology/hematology
Published: February 03, 2026
Correction: Capmatinib for the treatment of METex14 skipping non-small cell lung cancer: retrospective analysis of real-world data from patients receiving compassionate use treatment in Italy.
Journal: Clinical and experimental medicine
Published: December 17, 2025
Actionable driver gene alterations in early-stage non-small cell lung cancer: a review.
Journal: Therapeutic advances in medical oncology
Published: September 01, 2025
Management of MET-Driven Resistance to Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer.
Journal: Genes
Published: June 03, 2025
Capmatinib for the treatment of METex14 skipping non-small cell lung cancer: retrospective analysis of real-world data from patients receiving compassionate use treatment in Italy.
Journal: Clinical and experimental medicine
Published: May 28, 2025
HER2 in Non-Small Cell Lung Cancer (NSCLC): Evolution of the Therapeutic Landscape and Emerging Drugs-A Long Way to the Top.
Journal: Molecules (Basel, Switzerland)
Published: May 06, 2025
Dealing with KRAS G12C inhibition in non-small cell lung cancer (NSCLC) - biology, clinical results and future directions.
Journal: Cancer treatment reviews
Published: March 14, 2025
Management of Non-Metastatic Non-Small Cell Lung Cancer (NSCLC) with Driver Gene Alterations: An Evolving Scenario.
Journal: Current oncology (Toronto, Ont.)
Published: July 23, 2024
Non-Small-Cell Lung Cancers (NSCLCs) Harboring RET Gene Fusion, from Their Discovery to the Advent of New Selective Potent RET Inhibitors: "Shadows and Fogs".
Journal: Cancers
Published: July 16, 2024
Last Updated: 09/26/2026